Vasculitis and the ear: a literature review

被引：20
作者：
Rahne, Torsten [1 ]
Plontke, Stefan [1 ]
Keysser, Gernot [2 ]
机构：
[1] Martin Luther Univ Halle Wittenberg, Univ Med Halle, Dept Otorhinolaryngol Head & Neck Surg, Hate Ernst Grube Str 40, D-06120 Halle, Saale, Germany
[2] Martin Luther Univ Halle Wittenberg, Univ Med Halle, Dept Internal Med, Halle, Germany
来源：
CURRENT OPINION IN RHEUMATOLOGY | 2020年 / 32卷 / 01期
关键词：
cochlear implantation; ear manifestation; hearing loss; vasculitis; vestibular syndrome; SENSORINEURAL HEARING-LOSS; EOSINOPHILIC GRANULOMATOSIS; KAWASAKI-DISEASE; COGAN SYNDROME; POLYANGIITIS; INVOLVEMENT; MANIFESTATION; IMPAIRMENT; THROAT; HEAD;
D O I：
10.1097/BOR.0000000000000665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of review Systemic vasculitides as a group of inflammatory disorders of blood vessels may show clinical manifestations in the ear. This article reviews the recent literature about vasculitis of the ear or the cochleovestibular system, focusing on giant-cell arteritis, Takayasu's arteritis, polyarteritis nodosa, Kawasaki disease, microscopic polyangiitis, granulomatosis with polyangiitis (GPA), eosinophilic GPA, systemic lupus erythematosus, Cogan's syndrome and Behcet's disease. Recent findings In patients with vasculitis, hearing impairment is a frequent problem, followed by tinnitus and vertigo. The severity of sensorineural hearing loss can range from mild impairment to deafness. Autoimmune diseases can induce a conductive hearing loss as a result of effusions of the middle ear, the inflammation of the mucosa of the Eustachian tube, or the involvement of the ossicular chain. Vertigo may be caused by the temporary or permanent occlusion of the labyrinthine or the anterior vestibular artery. Middle ear inflammation is frequent in GPA and eosinophilic GPA. The progressive sensorineural hearing loss in polyarteritis nodosa or Cogan's syndrome patients may be treated by cochlear implantation.
引用
收藏
页码：47 / 52
页数：6
相关论文
共 40 条
  • [1] AGGARWAL V, 2016, ANN PEDIAT CARDIOL, V0009, P00087, DOI DOI 10.4103/0974-2069.171396
  • [2] ANDERSEN H, 2018, Z RHEUMATOL, V0077, P00928, DOI DOI 10.1007/S00393-018-0439-0
  • [3] BACCIU A, 2015, EUR ARCH OTO RHINO L, V0272, P03201, DOI DOI 10.1007/S00405-014-3376-9
  • [4] CANZI P, 2019, J INT ADV OTOL, V0015, P00156, DOI DOI 10.5152/IAO.2018.5463
  • [5] DELPERO MM, 2013, EUR ARCH OTO RHINO L, V0270, P00345, DOI DOI 10.1007/S00405-012-2110-8
  • [6] DESOUZA AWS, 2014, J AUTOIMMUN, V0048, P00079, DOI DOI 10.1016/J.JAUT.2014.01.012
  • [7] DISTADIO A, 2017, J INT MED RES, V0045, P01470, DOI DOI 10.1177/0300060516688600
  • [8] ERTUGRUL O, 2019, EUR ARCH OTO RHINO L, V0276, P01625, DOI DOI 10.1007/S00405-019-05403-X
  • [9] FELICETTI M, 2018, CLIN RHEUMATOL, V0037, P01075, DOI DOI 10.1007/S10067-018-4019-0
  • [10] FRAGOULIS GE, 2018, CLIN RHEUMATOL, V0037, P00737, DOI DOI 10.1007/S10067-017-3835-Y
1234